European Journal of Clinical Microbiology

, Volume 6, Issue 2, pp 190–190 | Cite as

Activity of LY146032 and vancomycin against coagulase-negative staphylococci

  • D. E. Low
  • R. Poon
New Antimicrobial Agents


Internal Medicine Vancomycin 


  1. 1.
    Eliopoulos, G. M., Thauvin, C., Gerson, B., Moellering, R. C.: In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic. Antimicrobial Agents and Chemotherapy 1985, 27: 357–362.PubMedGoogle Scholar
  2. 2.
    Archer G. L.: Antibiotic resistance in coagulase-negative Staphylococci. In: Mardh, P. A., Schleifer, K. H. (ed.): Coagulase-negative Staphylococci. Almqvist and Wilksell Stockholm, 1986, p. 93–101.Google Scholar
  3. 3.
    National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, M7-A. Villanova, PA, 1985.Google Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1987

Authors and Affiliations

  • D. E. Low
    • 1
  • R. Poon
    • 1
  1. 1.Department of MicrobiologyMount Sinai HospitalTorontoCanada

Personalised recommendations